NextCure Inc $ 11.39 -0.15 (-1.3%)
Volume:
338,385
Avg Vol (1m):
255,304
Market Cap $:
313.83 Mil
Enterprise Value $:
26.51 Mil
PE Ratio:
0.00
PB Ratio:
1.01
Financial Strength | 5/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 74.88 | ||
| Debt-to-Equity | 0.01 | ||
| Debt-to-EBITDA | -0.12 | ||
| Altman Z-Score | 22.23 | ||
| Beneish M-Score | 0 | ||
| WACC vs ROIC | |||
Profitability Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -142.49 | ||
| Net Margin % | -123.5 | ||
| ROE % | -11.03 | ||
| ROA % | -10.32 | ||
| ROC (Joel Greenblatt) % | -267.11 |
NXTC
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 1.01 | ||
| PS Ratio | 13.64 | ||
| EV-to-EBIT | -0.73 | ||
| EV-to-EBITDA | -0.73 | ||
| EV-to-Revenue | 1.04 | ||
| Current Ratio | 51.73 | ||
| Quick Ratio | 51.73 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History |
|---|
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 1.02 | ||
| Earnings Yield (Greenblatt) % | -139.26 |